v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2026
Dec. 31, 2025
Investment securities, fair value $ 1,490 $ 1,532
Investment securities, amortized cost basis 1,601 1,584
Net finance receivables 26,273 24,833
Financing receivable, allowance for credit loss 3,069 2,865
Restricted cash and restricted cash equivalents 751 699
Long-term debt 24,074 22,694
Other liabilities $ 704 $ 682
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 114,575,373 117,196,792
Common stock, shares outstanding (in shares) 114,575,373 117,196,792
Treasury stock at cost (in shares) 21,475,215 18,514,904
Consolidated VIEs    
Net finance receivables $ 14,652 $ 13,418
Financing receivable, allowance for credit loss 1,723 1,558
Restricted cash and restricted cash equivalents 729 690
Long-term debt 12,661 11,464
Other liabilities $ 32 $ 30